참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Boron trifluoride etherate | HCID 8000 | — |
| 반응물 | Chromanone | HCID 68110 | — |
| 반응물 | Trimethylsilyldiazomethane | HCID 167693 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 용매 | Sodium Bicarbonate | HCID 516892 | — |
| 생성물 | 2,3,4,5-Tetrahydro-1-benzoxepin-4-one | HCID 12580031 | — |
반응 단계
To a solution of 4-chromanone (9.54 g, 64.3 mmol) in diethyl ether at 0° C. was slowly added boron trifluoride diethyl etherate (16.3 ml, 128.6 mmol), followed by the dropwise addition of 2M TMSCHN2 in diethyl ether. The mixture was allowed to stir for 1 hour at 0° C. before diluting with sat. sodium bicarbonate solution and diethyl ether. The organic phase was dried, concentrated, and purified on silica to give 2,3-dihydro-5H-benzo[b]oxepin-4-one.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08846762B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_09 |
|---|
| ORD ID | ord-a84fee2c41ce4e6b9f045d6d307b4e1b |
|---|
| 출처 메모 | uspto-grants-2014_09 |
|---|